Lineage Cell Therapeutics, Inc. (LCTX)
$1.09+0.93%Close
SELLRECOVERY · day 4
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $272M
- Avg volume
- 1.3M
- Beta
- 1.55
- P/E (TTM)
- -7.88
- Short % float
- 12.50%
- Days to cover
- 26.2
- SI change
- -1.0%
- 1W
- +2.83%
- 1M
- +5.83%
- 3M
- -16.15%
- YTD
- -33.54%
- vs SPY 1W
- +4.02%
- vs SPY 1M
- +2.50%
- vs SPY 3M
- -18.55%
- vs SPY YTD
- -45.29%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CDIOBUYCardio Diagnostics Holdings, Inc.CRISISQ -18$1.93-4.93%
- XCURSELLExicure, Inc.CRISISQ -13$1.15+0.00%
- VBIOSELLMalachite Innovations, Inc.CRISISQ -28$0.17+41.67%
- ISPCSELLiSpecimen Inc.CRISISQ -26$1.57-7.10%
- BOLTSELLBolt Biotherapeutics, Inc.RECOVERYQ -39$3.74+1.91%
- CVRXSELLCVRx, Inc.CRISISQ -21$3.15+10.92%
- PTHSSELLPelthos Therapeutics Inc.RECOVERYQ 4$26.62+4.35%
- ENSCBUYEnsysce Biosciences, Inc.CRISISQ -25$0.36-2.70%
- CAMPBUYCAMP4 Therapeutics CorporationCRISISQ -5$4.32-3.57%
- CBIOBUYCrescent Biopharma, Inc.RECOVERYQ -1$16.97-1.05%
- TLSIBUYTriSalus Life Sciences, Inc.RECOVERYQ -6$5.11-3.04%
- VTVTBUYvTv Therapeutics Inc.RECOVERYQ 3$33.89+1.89%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
